PKA Inhibitors

PKA

PKAR

PKACα

PKA Inhibitors, Agonists & Activators

Product Name	PKA	PKAR	PKACα	Purity
Bucladesine sodium	PKA			99.48%
GSK-3α/β-IN-1	PKA, IC₅₀: 0.188 μM
Fasudil Hydrochloride	PKA, IC₅₀: 4.58 μM			99.97%
Bucladesine calcium	PKA			98.63%
Daphnetin	PKA, IC₅₀: 9.33 μM			99.77%
KT5823	PKA, Ki: 10 μM			99.90%
Bilobetin	PKA			99.39%
AT7867	PKA, IC₅₀: 20 nM			99.85%
AT13148	PKA, IC₅₀: 3 nM			99.20%
PKA Inhibitor Fragment (6-22) amide TFA	PKA, Ki: 2.8 nM			99.87%
CW 008	PKA			98.15%
AT7867 dihydrochloride	PKA, IC₅₀: 20 nM			99.75%
Sp-cAMPS sodium salt	PKA I PKA II			99.45%
Hu7691	PKA, IC₅₀: 11 nM			99.91%
Fasudil	PKA, IC₅₀: 4.58 μM			99.91%
Jaspamycin	Trypanosoma brucei PKA holoenzyme, Kd: 8 nM	Trypanosoma brucei PKAR(199-499), EC₅₀: 6.5 nM		98.94%
Undecane	PKA			99.66%
PF-4950834	PKA, IC₅₀: 424 nM			99.60%
PKC-IN-6	PKA, IC₅₀: >500 μM			99.63%
Sp-cAMPS	PKA I PKA II
Fasudil dihydrochloride	PKA, IC₅₀: 4.58 μM			99.98%
Sp-8-Br-cAMPS sodium	PKA, EC₅₀: 360 nM			99.70%
A-3 hydrochloride	PKA, Ki: 4.3 μM			99.75%
Akt1&PKA-IN-1	PKAa, IC₅₀: 0.03 μM
Hu7691 free base	PKA, IC₅₀: 11 nM
Fasudil hydrochloride semihydrate	PKA, IC₅₀: 4.58 μM
Sp-cAMPS triethylamine	PKA I PKA II
PKA Inhibitor Fragment (6-22) amide	PKA, Ki: 2.8 nM
HA-100 dihydrochloride	PKA, IC₅₀: 8 μM
GSK466317A	PKA, IC₅₀: 12.59 μM
HA-100 hydrochloride	PKA, IC₅₀: 8 μM
PKA-IN-2			J-PKACα, IC₅₀: 6.3 nM
LX7101 monohydrochloride	PKA, IC₅₀: <1 nM
Balanol	PKA

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
粤ICP备2021105330号-3 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明